Related Experiment Video

Updated: May 18, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Association between pre-eclampsia and inherited thrombophilias

Rüya Deveer1, Yaprak Engin-Ustun, Eren Akbaba

  • 1Zekai Tahir Burak Women Health Research and Education Hospital, Ankara, Turkey. deveer3@hotmail.com

Fetal and Pediatric Pathology
|September 26, 2012
PubMed

Insights

This study found no link between inherited thrombophilias, such as factor V Leiden, and the risk or course of pre-eclampsia (PE). Inherited clotting disorders do not appear to be a significant factor in developing PE.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Genetics

Background:

  • Pre-eclampsia (PE) is a serious pregnancy complication.
  • Inherited thrombophilias are genetic conditions affecting blood clotting.
  • The potential association between thrombophilia and PE requires further investigation.

Observation:

  • This study compared 50 patients with severe PE to 50 healthy pregnant women.
  • Inherited thrombophilia screening was performed on all participants.
  • Factor V Leiden (FVL) carrier status was assessed, along with other thrombophilic factors.

Findings:

  • Factor V Leiden carrier rates were similar between the PE group (14 patients) and the control group (12%).
  • No increased prevalence of FVL or other inherited thrombophilias was observed in women with PE compared to controls.
  • The study did not demonstrate a statistically significant association.

Implications:

  • Current findings suggest inherited thrombophilias may not be a major risk factor for pre-eclampsia.
  • Further research is needed to explore other potential genetic or environmental factors in PE.
  • Clinical screening for inherited thrombophilias in PE patients may not be indicated based on this evidence.
Abstract

More Related Videos

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis06:03

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis

Published on: July 12, 2011

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Probability Laws01:49

Probability Laws

Overview